SCHEMBL1765896

SCHEMBL1765896

C[C](C)c1ccc2ccccc2n1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGAM O43451 1/20 0.61
LMNA P02545 1/20 0.58
CNR2 P34972 5/20 0.55
HDAC8 Q9BY41 1/20 0.55
ALDH1A1 P00352 2/20 0.53
GAA P10253 1/20 0.53
MAPT P10636 1/20 0.53
CYP1A2 P05177 1/20 0.52
RAB9A P51151 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
KDM4E B2RXH2 1/20 0.50
NFKB1 P19838 1/20 0.50
NFKB2 Q00653 1/20 0.50
RELA Q04206 1/20 0.50
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
NCF1 P14598 3/20 0.48
HPGD P15428 2/20 0.47
NPC1 O15118 1/20 0.47
TP53 P04637 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29484746 0.83 MGAM (0.68) MGAMLMNACNR2HDAC8ALDH1A1
SCHEMBL31080661 0.83 MGAM (0.57) MGAMLMNACNR2HDAC8ALDH1A1
SCHEMBL28879874 0.83 LMNA (0.65) MGAMLMNACNR2HDAC8ALDH1A1
SCHEMBL611196 0.83 MGAM (0.57) MGAMLMNACNR2HDAC8ALDH1A1
SCHEMBL403888 0.83 MGAM (0.68) MGAMLMNACNR2HDAC8ALDH1A1
SCHEMBL29484748 0.83 MGAM (0.68) MGAMLMNACNR2HDAC8ALDH1A1
Hydrochloric Acid SCHEMBL3199562 0.81 MGAM (0.66) MGAMLMNACNR2HDAC8ALDH1A1
SCHEMBL19046659 0.81 MGAM (0.55) MGAMLMNACNR2HDAC8ALDH1A1
SCHEMBL8307051 0.79 MGAM (0.53) MGAMLMNACNR2HDAC8ALDH1A1
SCHEMBL1343443 0.77 CNR2 (0.78) MGAMLMNACNR2HDAC8ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2464349-A2 USE OF PPAR DELTA LIGANDS FOR THE TREATMENT OR PREVENTION OF INFLAMMATION OR ENERGY METABOLISM/PRODUCTION RELATED DISEASES Cerenis Therapeutics S.A. (FR) 2012-06-20 EP disclosed
WO-2011020001-A9 USE OF PPAR DELTA LIGANDS FOR THE TREATMENT OR PREVENTION OF INFLAMMATION OR ENERGY METABOLISM/PRODUCTION RELATED DISEASES CERENIS THERAPEUTICS S.A. (FR) 2011-05-26 WO disclosed
WO-2011020001-A2 USE OF PPAR DELTA LIGANDS FOR THE TREATMENT OR PREVENTION OF INFLAMMATION OR ENERGY METABOLISM/PRODUCTION RELATED DISEASES CERENIS THERAPEUTICS S.A. (FR) 2011-02-17 WO disclosed
WO-2008154023-A1 NOVEL USES OF PPAR DELTA AGONISTS CERENIS THERAPEUTICS S.A. (FR) 2008-12-18 WO disclosed